loadpatents
name:-0.13775420188904
name:-0.11530184745789
name:-0.064661979675293
Li; Liansheng Patent Filings

Li; Liansheng

Patent Applications and Registrations

Patent applications and USPTO patent grants for Li; Liansheng.The latest application filed is for "certain chemical entities, compositions and methods".

Company Profile
61.115.137
  • Li; Liansheng - San Diego CA
  • Li; Liansheng - La Jolla CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Certain chemical entities, compositions and methods
Grant 11,433,065 - Ren , et al. September 6, 2
2022-09-06
Certain Chemical Entities, Compositions And Methods
App 20220265637 - REN; Pingda ;   et al.
2022-08-25
Inhibitors Of Kras G12c
App 20220242875 - LI; Liansheng ;   et al.
2022-08-04
Covalent inhibitors of KRAS
Grant 11,377,441 - Li , et al. July 5, 2
2022-07-05
Benzothiophene and benzothiazole compounds and methods of use thereof
Grant 11,358,959 - Li , et al. June 14, 2
2022-06-14
Compounds And Methods Of Use Thereof For Treatment Of Cancer
App 20220112192 - LI; Liansheng ;   et al.
2022-04-14
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer
Grant 11,279,689 - Li , et al. March 22, 2
2022-03-22
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
Grant 11,274,093 - Li , et al. March 15, 2
2022-03-15
2-(2-acryloyl-2,6-diazaspiro[3.4]octan-6-yl)-6-(1h-indazol-4-yl)-benzonitr- Ile Derivatives And Related Compounds As Inhibitors Of G12c Mutant Kras Protein For Inhibiting Tumor Metastasis
App 20210380595 - LI; Liansheng ;   et al.
2021-12-09
Heterocyclic Spiro Compounds And Methods Of Use Thereof For The Treatment Of Cancer
App 20210317127 - LI; Liansheng ;   et al.
2021-10-14
Substituted quinazoline and quinazolinone compounds and methods of use thereof
Grant 11,136,308 - Li , et al. October 5, 2
2021-10-05
Fused hetero-hetero bicyclic compounds and methods of use thereof
Grant 11,059,819 - Li , et al. July 13, 2
2021-07-13
Inhibitors Of Kras G12c
App 20210188869 - LI; Liansheng ;   et al.
2021-06-24
2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof
Grant 11,021,470 - Li , et al. June 1, 2
2021-06-01
Bridged Bicyclic Inhibitors Of Menin-mll And Methods Of Use
App 20210107917 - WU; Tao ;   et al.
2021-04-15
Inhibitors of KRAS G12C mutant proteins
Grant 10,975,071 - Li , et al. April 13, 2
2021-04-13
Substituted Inhibitors Of Menin-mll And Methods Of Use
App 20210101908 - WU; Tao ;   et al.
2021-04-08
Substituted cinnolines as inhibitors of KRAS G12C
Grant 10,927,125 - Li , et al. February 23, 2
2021-02-23
Covalent inhibitors of KRas G12C
Grant 10,919,850 - Ren , et al. February 16, 2
2021-02-16
Covalent Inhibitors Of Kras
App 20210024501 - Li; Liansheng ;   et al.
2021-01-28
Inhibitors of KRAS G12C mutant proteins
Grant 10,882,847 - Li , et al. January 5, 2
2021-01-05
Inhibitors of KRAS G12C mutant proteins
Grant 10,875,842 - Li , et al. December 29, 2
2020-12-29
Fused N-heterocyclic Compounds And Methods Of Use Thereof
App 20200385364 - Li; Liansheng ;   et al.
2020-12-10
Inhibitors of KRAS G12C mutant proteins
Grant 10,858,343 - Li , et al. December 8, 2
2020-12-08
Substituted quinazoline compounds and methods of use thereof
Grant 10,829,458 - Li , et al. November 10, 2
2020-11-10
Substituted quinazoline compounds and methods of use
Grant 10,822,312 - Li , et al. November 3, 2
2020-11-03
Substituted inhibitors of menin-MLL and methods of use
Grant 10,781,218 - Wu , et al. Sept
2020-09-22
Bridged bicyclic inhibitors of menin-MLL and methods of use
Grant 10,752,639 - Wu , et al. A
2020-08-25
Covalent inhibitors of KRAS
Grant 10,745,385 - Li , et al. A
2020-08-18
Compounds and methods of use thereof for treatment of cancer
Grant 10,736,897 - Li , et al. A
2020-08-11
Inhibitors of KRAS G12C mutant proteins
Grant 10,730,867 - Li , et al.
2020-08-04
Inhibitors of KRAS G12C mutant proteins
Grant 10,723,738 - Li , et al.
2020-07-28
Certain Chemical Entities, Compositions And Methods
App 20200222384 - Ren; Pingda ;   et al.
2020-07-16
Substituted Inhibitors Of Menin-mll And Methods Of Use
App 20200216471 - WU; Tao ;   et al.
2020-07-09
Inhibitors of KRAS G12C mutant proteins
Grant 10,689,356 - Li , et al.
2020-06-23
2-substituted Quinazoline Compounds Comprising A Substituted Heterocyclic Group And Methods Of Use Thereof
App 20200181123 - Li; Liansheng ;   et al.
2020-06-11
Methods And Compositions For Inhibiting The Interaction Of Menin With Mll Proteins
App 20200165224 - LI; Liansheng ;   et al.
2020-05-28
Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
Grant 10,646,488 - Liu , et al.
2020-05-12
Inhibitors of KRAS G12C mutant proteins
Grant 10,647,703 - Li , et al.
2020-05-12
Quinazoline Derivatives As Modulators Of Mutant Kras, Hras Or Nras
App 20200115363 - LI; Liansheng ;   et al.
2020-04-16
Substituted Quinazolines As Inhibitors Of Kras G12c
App 20200102321 - LI; Liansheng ;   et al.
2020-04-02
Methods and compositions for inhibiting the interaction of menin with MLL proteins
Grant 10,588,907 - Grembecka , et al.
2020-03-17
Inhibitors Of Kras G12c Mutant Proteins
App 20200062761 - Li; Liansheng ;   et al.
2020-02-27
Substituted Quinazoline And Quinazolinone Compounds And Methods Of Use Thereof
App 20200010454 - Li; Liansheng ;   et al.
2020-01-09
Benzothiophene And Benzothiazole Compounds And Methods Of Use Thereof
App 20190389851 - Li; Liansheng ;   et al.
2019-12-26
Covalent Inhibitors Of Kras G12c
App 20190389796 - Ren; Pingda ;   et al.
2019-12-26
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 Yl)prop-2-en-1-one Derivatives And Similar Compounds As Kras G12c M
App 20190382377 - Li; Liansheng ;   et al.
2019-12-19
Fused Bicyclic Benzoheteroaromatic Compounds And Methods Of Use Thereof
App 20190367489 - Li; Liansheng ;   et al.
2019-12-05
Heterocyclic Compounds and Uses Thereof
App 20190350906 - Ren; Pingda ;   et al.
2019-11-21
Fused Hetero-hetero Bicyclic Compounds And Methods Of Use Thereof
App 20190345158 - Li; Liansheng ;   et al.
2019-11-14
Fused-tricyclic inhibitors of KRAS and methods of use thereof
Grant 10,428,064 - Li , et al. October 1, 2
2019-10-01
Certain Chemical Entities, Compositions And Methods
App 20190290636 - Ren; Pingda ;   et al.
2019-09-26
Inhibitors Of Erk And Methods Of Use
App 20190292194 - Li; Liansheng ;   et al.
2019-09-26
Substituted Quinazoline Compounds And Methods Of Use Thereof
App 20190284144 - Li; Liansheng ;   et al.
2019-09-19
2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof
Grant 10,414,757 - Li , et al. Sept
2019-09-17
Combination Therapies For Treatment Of Cancer
App 20190262342 - Janes; Matthew Robert ;   et al.
2019-08-29
Inhibitors of RAS and methods of use thereof
Grant 10,377,743 - Li , et al. A
2019-08-13
Substituted quinolines as inhibitors of KRAS G12C
Grant 10,370,386 - Li , et al.
2019-08-06
Substituted quinazoline compounds and methods of use thereof
Grant 10,351,550 - Li , et al. July 16, 2
2019-07-16
Inhibitors of ERK and methods of use
Grant 10,301,317 - Li , et al.
2019-05-28
Inhibitors of KRAS G12C mutant proteins
Grant 10,280,172 - Li , et al.
2019-05-07
Substituted Quinazoline Compounds And Methods Of Use
App 20190127336 - LI; LIANSHENG ;   et al.
2019-05-02
Covalent inhibitors of kras G12C
Grant 10,273,207 - Ren , et al.
2019-04-30
Substituted quinazoline compounds and methods of use thereof
Grant 10,246,424 - Li , et al.
2019-04-02
Thienopyrimidine and thienopyridine compounds and methods of use thereof
Grant 10,246,464 - Grembecka , et al.
2019-04-02
Substituted Inhibitors Of Menin-mll And Methods Of Use
App 20190092784 - Wu; Tao ;   et al.
2019-03-28
Bridged Bicyclic Inhibitors Of Menin-mll And Methods Of Use
App 20190092783 - Wu; Tao ;   et al.
2019-03-28
Inhibitors Of Kras G12c Mutant Proteins
App 20190092767 - Li; Liansheng ;   et al.
2019-03-28
Covalent Inhibitors Of Kras
App 20190062313 - Li; Liansheng ;   et al.
2019-02-28
Compounds And Methods Of Use Thereof For Treatment Of Cancer
App 20190062314 - Li; Liansheng ;   et al.
2019-02-28
Inhibitors Of Kras G12c Mutant Proteins
App 20190055211 - Li; Liansheng ;   et al.
2019-02-21
Methods and compositions for inhibiting the interaction of menin with MLL proteins
Grant 10,174,041 - Grembecka , et al. J
2019-01-08
Substituted quinazoline compounds and methods of use thereof
Grant 10,144,724 - Li , et al. De
2018-12-04
Methods And Compositions For Inhibiting The Interaction Of Menin With Mll Proteins
App 20180327414 - Grembecka; Jolanta ;   et al.
2018-11-15
Inhibitors Of Kras G12c Mutant Proteins
App 20180319775 - LI; Liansheng ;   et al.
2018-11-08
Combination therapies for treatment of cancer
Grant 10,111,874 - Janes , et al. October 30, 2
2018-10-30
Inhibitors Of Kras G12c Mutant Proteins
App 20180282307 - Li; Liansheng ;   et al.
2018-10-04
Inhibitors Of Kras G12c Mutant Proteins
App 20180282308 - Li; Liansheng ;   et al.
2018-10-04
Inhibitors Of Kras G12c Mutant Proteins
App 20180273523 - Li; Liansheng ;   et al.
2018-09-27
Inhibitors Of Kras G12c Mutant Proteins
App 20180273515 - Li; Liansheng ;   et al.
2018-09-27
Methods and compositions for inhibiting the interaction of menin with MLL proteins
Grant 10,077,271 - Grembecka , et al. September 18, 2
2018-09-18
Certain Chemical Entities, Compositions And Methods
App 20180258103 - Ren; Pingda ;   et al.
2018-09-13
Methods And Compositions For Inhibiting The Interaction Of Menin With Mll Proteins
App 20180243303 - GREMBECKA; Jolanta ;   et al.
2018-08-30
Method For Screening Inhibitors Of Ras
App 20180246102 - Patricelli; Matthew P. ;   et al.
2018-08-30
Inhibitors Of Erk And Methods Of Use
App 20180237444 - Li; Liansheng ;   et al.
2018-08-23
Substituted Quinazoline Compounds And Methods Of Use Thereof
App 20180194748 - Li; Liansheng ;   et al.
2018-07-12
Methods and compositions for inhibition of Ras
Grant 10,011,600 - Li , et al. July 3, 2
2018-07-03
Covalent Inhibitors Of Kras G12c
App 20180162812 - Ren; Pingda ;   et al.
2018-06-14
Inhibitors Of Kras G12c Mutant Proteins
App 20180155348 - Li; Liansheng ;   et al.
2018-06-07
Methods for preparation of quinazoline derivatives
Grant 9,988,357 - Mani , et al. June 5, 2
2018-06-05
Inhibitors Of Kras G12c Mutant Proteins
App 20180141927 - Li; Liansheng ;   et al.
2018-05-24
Inhibitors Of Ras And Methods Of Use Thereof
App 20180127396 - Li; Liansheng ;   et al.
2018-05-10
Substituted Quinazolines As Inhibitors Of Kras G12c
App 20180118757 - Li; Liansheng ;   et al.
2018-05-03
Inhibitors of ERK and methods of use
Grant 9,951,078 - Li , et al. April 24, 2
2018-04-24
Methods And Compositions For Inhibiting The Interaction Of Menin With Mll Proteins
App 20180105531 - Grembecka; Jolanta ;   et al.
2018-04-19
Certain Chemical Entities, Compositions And Methods
App 20180098983 - REN; Pingda ;   et al.
2018-04-12
Fused-tricyclic Inhibitors Of Kras And Methods Of Use Thereof
App 20180086753 - Li; Liansheng ;   et al.
2018-03-29
Covalent inhibitors of K-Ras G12C
Grant 9,926,267 - Ren , et al. March 27, 2
2018-03-27
Heterocyclic Compounds and Uses Thereof
App 20180042902 - Ren; Pingda ;   et al.
2018-02-15
Conjugates Of Cereblon Binding Compounds And G12c Mutant Kras, Hras Or Nras Protein Modulating Compounds And Methods Of Use Thereof
App 20180015087 - Liu; Yi ;   et al.
2018-01-18
Inhibitors of KRAS G12C mutant proteins
Grant 9,862,701 - Li , et al. January 9, 2
2018-01-09
Substituted quinazolines as inhibitors of KRAS G12C
Grant 9,840,516 - Li , et al. December 12, 2
2017-12-12
Kinase inhibitors and methods of use
Grant 9,828,378 - Ren , et al. November 28, 2
2017-11-28
Certain chemical entities, compositions and methods
Grant 9,822,131 - Ren , et al. November 21, 2
2017-11-21
Method for screening inhibitors of Ras
Grant 9,810,690 - Patricelli , et al. November 7, 2
2017-11-07
Heterocyclic kinase inhibitors
Grant 9,790,228 - Ren , et al. October 17, 2
2017-10-17
Certain Chemical Entities, Compositions And Methods
App 20170281614 - Ren; Pingda ;   et al.
2017-10-05
Methods And Compositions For Inhibition Of Ras
App 20170247376 - LI; Liansheng ;   et al.
2017-08-31
Thienopyrimidine And Thienopyridine Compounds And Methods Of Use Thereof
App 20170247391 - Grembecka; Jolanta ;   et al.
2017-08-31
Irreversible covalent inhibitors of the GTPase K-Ras G12C
Grant 9,745,319 - Ren , et al. August 29, 2
2017-08-29
Chemical compounds, compositions and methods for kinase modulation
Grant 9,738,644 - Ren , et al. August 22, 2
2017-08-22
Inhibitors Of Erk And Methods Of Use
App 20170226110 - LI; Liansheng ;   et al.
2017-08-10
Heterocyclic compounds and uses thereof
Grant 9,718,815 - Castro , et al. August 1, 2
2017-08-01
2-substituted Quinazoline Compounds Comprising A Substituted Heterocyclic Group And Methods Of Use Thereof
App 20170197945 - Li; Liansheng ;   et al.
2017-07-13
Methods For Preparation Of Quinazoline Derivatives
App 20170190672 - Mani; Neelakandha S. ;   et al.
2017-07-06
Certain chemical entities, compositions and methods
Grant 9,655,892 - Ren , et al. May 23, 2
2017-05-23
Heterocyclic Compounds And Uses Thereof
App 20170137407 - Castro; Alfredo C. ;   et al.
2017-05-18
Method For Screening Inhibitors Of Ras
App 20170131278 - Patricelli; Matthew P. ;   et al.
2017-05-11
Benzothiazole kinase inhibitors and methods of use
Grant 9,637,492 - Ren , et al. May 2, 2
2017-05-02
MTOR modulators and uses thereof
Grant 9,629,843 - Shokat , et al. April 25, 2
2017-04-25
Inhibitors of ERK and methods of use
Grant 9,624,228 - Li , et al. April 18, 2
2017-04-18
Heterocyclic compounds and uses thereof
Grant 9,605,003 - Castro , et al. March 28, 2
2017-03-28
Substituted Quinazoline Compounds And Methods Of Use Thereof
App 20170022184 - Li; Liansheng ;   et al.
2017-01-26
Heterocyclic compounds and uses thereof
Grant 9,546,180 - Castro , et al. January 17, 2
2017-01-17
Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof
Grant 9,522,146 - Ren , et al. December 20, 2
2016-12-20
Substituted Quinazoline Compounds And Methods Of Use Thereof
App 20160297774 - Li; Liansheng ;   et al.
2016-10-13
Benzoxazole Kinase Inhibitors and Methods of Use
App 20160287596 - Ren; Pingda ;   et al.
2016-10-06
Inhibitors Of Erk And Methods Of Use
App 20160237091 - LI; Liansheng ;   et al.
2016-08-18
Heterocyclic Compounds And Uses Thereof
App 20160207940 - CASTRO; Alfredo C. ;   et al.
2016-07-21
Heterocyclic compounds and uses thereof
Grant 9,388,183 - Ren , et al. July 12, 2
2016-07-12
Certain Chemical Entities, Compositions And Methods
App 20160185800 - REN; Pingda ;   et al.
2016-06-30
Heterocyclic Kinase Inhibitors
App 20160168157 - REN; Pingda ;   et al.
2016-06-16
Combination Therapies For Treatment Of Cancer
App 20160166571 - Janes; Matthew Robert ;   et al.
2016-06-16
Certain Chemical Entities, Compositions And Methods
App 20160158239 - REN; Pingda ;   et al.
2016-06-09
Covalent Inhibitors Of Kras G12c
App 20160159738 - Ren; Pingda ;   et al.
2016-06-09
Substituted benzimidazoles as PI3 kinase inhibitors
Grant 9,359,352 - Ren , et al. June 7, 2
2016-06-07
Benzoxazole kinase inhibitors and methods of use
Grant 9,345,706 - Ren , et al. May 24, 2
2016-05-24
Inhibitors Of Kras G12c Mutant Proteins
App 20160108019 - Li; Liansheng ;   et al.
2016-04-21
Heterocyclic compounds and uses thereof
Grant 9,315,505 - Ren , et al. April 19, 2
2016-04-19
Heterocyclic kinase inhibitors
Grant 9,296,742 - Ren , et al. March 29, 2
2016-03-29
Heterocyclic compounds and uses thereof
Grant 9,255,108 - Castro , et al. February 9, 2
2016-02-09
Certain Chemical Entities, Compositions And Methods
App 20160031886 - REN; Pingda ;   et al.
2016-02-04
Irreversible Covalent Inhibitors Of The Gtpase K-ras G12c
App 20160031898 - Ren; Pingda ;   et al.
2016-02-04
Kinase Inhibitors And Methods Of Use
App 20160024099 - Ren; Pingda ;   et al.
2016-01-28
Chemical Compounds, Compositions And Methods For Kinase Modulation
App 20160016957 - REN; Pingda ;   et al.
2016-01-21
Mtor Modulators And Uses Thereof
App 20160000789 - Shokat; Kevan M. ;   et al.
2016-01-07
Covalent inhibitors of Kras G12C
Grant 9,227,978 - Ren , et al. January 5, 2
2016-01-05
Certain chemical entities, compositions and methods
Grant 9,216,982 - Ren , et al. December 22, 2
2015-12-22
Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof
Grant 9,206,182 - Ren , et al. December 8, 2
2015-12-08
Heterocyclic Compounds And Uses Thereof
App 20150320727 - Ren; Pingda ;   et al.
2015-11-12
Heterocyclic Compounds and Uses Thereof
App 20150322064 - Ren; Pingda ;   et al.
2015-11-12
Chemical compounds, compositions and methods for kinase modulation
Grant 9,181,221 - Ren , et al. November 10, 2
2015-11-10
Benzoxazole Kinase Inhibitors And Methods Of Use
App 20150306105 - Ren; Pingda ;   et al.
2015-10-29
Heterocyclic compounds and uses thereof
Grant 9,127,000 - Ren , et al. September 8, 2
2015-09-08
Heterocyclic Compounds And Uses Thereof
App 20150246932 - CASTRO; Alfredo C. ;   et al.
2015-09-03
Inhibitors Of Kras G12c
App 20150239900 - Li; Liansheng ;   et al.
2015-08-27
Substituted isoquinolinones and methods of treatment thereof
Grant 9,115,141 - Castro , et al. August 25, 2
2015-08-25
Benzothiazole Kinase Inhibitors and Methods of Use
App 20150225407 - Ren; Pingda ;   et al.
2015-08-13
Substituted benzoxazoles as PI3 kinase inhibitors
Grant 9,096,590 - Ren , et al. August 4, 2
2015-08-04
Kinase inhibitors and methods of use
Grant 9,096,611 - Ren , et al. August 4, 2
2015-08-04
Heterocyclic compounds and uses thereof
Grant 9,085,560 - Ren , et al. July 21, 2
2015-07-21
Heterocyclic compounds and uses thereof
Grant 9,056,877 - Castro , et al. June 16, 2
2015-06-16
Heterocyclic Compounds And Uses Thereof
App 20150158859 - Ren; Pingda ;   et al.
2015-06-11
Heterocyclic Compounds And Uses Thereof
App 20150126506 - CASTRO; Alfredo C. ;   et al.
2015-05-07
Heterocyclic Compounds And Uses Thereof
App 20150105385 - CASTRO; Alfredo C. ;   et al.
2015-04-16
Benzothiazole kinase inhibitors and methods of use
Grant 8,993,580 - Ren , et al. March 31, 2
2015-03-31
Heterocyclic compounds and uses thereof
Grant 8,969,363 - Castro , et al. March 3, 2
2015-03-03
Heterocyclic Compounds And Uses Thereof
App 20150031672 - Ren; Pingda ;   et al.
2015-01-29
Heterocyclic compounds and uses thereof
Grant 8,940,742 - Castro , et al. January 27, 2
2015-01-27
Heterocyclic compounds and uses thereof
Grant 8,901,133 - Ren , et al. December 2, 2
2014-12-02
Certain Chemical Entities, Compositions And Methods
App 20140341894 - REN; Pingda ;   et al.
2014-11-20
Heterocyclic Compounds And Uses Thereof
App 20140323721 - Ren; Pingda ;   et al.
2014-10-30
Heterocyclic Compounds And Uses Thereof
App 20140296207 - REN; Pingda ;   et al.
2014-10-02
Heterocyclic Compounds And Uses Thereof
App 20140288048 - CASTRO; Alfredo C. ;   et al.
2014-09-25
Covalent Inhibitors Of Kras G12c
App 20140288045 - Ren; Pingda ;   et al.
2014-09-25
Certain Chemical Entities, Compositions And Methods
App 20140206684 - REN; Pingda ;   et al.
2014-07-24
Heterocyclic Kinase Inhibitors
App 20140206685 - REN; Pingda ;   et al.
2014-07-24
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
Grant 8,785,456 - Ren , et al. July 22, 2
2014-07-22
Heterocyclic compounds and uses thereof
Grant 8,785,470 - Castro , et al. July 22, 2
2014-07-22
Heterocyclic compounds and uses thereof
Grant 8,785,454 - Ren , et al. July 22, 2
2014-07-22
Benzoxazole Kinase Inhibitors And Methods Of Use
App 20140128599 - Ren; Pingda ;   et al.
2014-05-08
Heterocyclic kinase inhibitors
Grant 8,703,778 - Ren , et al. April 22, 2
2014-04-22
Certain chemical entities, compositions and methods
Grant 8,703,777 - Ren , et al. April 22, 2
2014-04-22
Heterocyclic Compounds And Uses Thereof
App 20140100214 - CASTRO; Alfredo C. ;   et al.
2014-04-10
Chemical Compounds, Compositions And Methods For Kinase Modulation
App 20140088099 - REN; Pingda ;   et al.
2014-03-27
Benzoxazole Kinase Inhibitors And Methods Of Use
App 20140030256 - Ren; Pingda ;   et al.
2014-01-30
Kinase inhibitors and methods of use
Grant 8,637,542 - Liu , et al. January 28, 2
2014-01-28
Certain Chemical Entities, Compositions And Methods
App 20130345216 - Ren; Pingda ;   et al.
2013-12-26
Chemical compounds, compositions and methods for kinase modulation
Grant 8,604,032 - Ren , et al. December 10, 2
2013-12-10
Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof
Grant 8,569,323 - Ren , et al. October 29, 2
2013-10-29
Heterocyclic Compounds And Uses Thereof
App 20130267521 - CASTRO; Alfredo C. ;   et al.
2013-10-10
Heterocyclic Compounds And Uses Thereof
App 20130261102 - Ren; Pingda ;   et al.
2013-10-03
Benzoxazole kinase inhibitors and methods of use
Grant 8,476,431 - Ren , et al. July 2, 2
2013-07-02
Benzoxazole kinase inhibitors and methods of use
Grant 8,476,282 - Ren , et al. July 2, 2
2013-07-02
Heterocyclic Compounds And Uses Thereof
App 20130053362 - CASTRO; Alfredo C. ;   et al.
2013-02-28
Heterocyclic Compounds And Uses Thereof
App 20130035324 - Ren; Pingda ;   et al.
2013-02-07
Heterocyclic Compounds And Uses Thereof
App 20130029982 - Castro; Alfredo C. ;   et al.
2013-01-31
Heterocyclic Compounds And Uses Thereof
App 20130029984 - Castro; Alfredo C. ;   et al.
2013-01-31
Heterocyclic Compounds And Uses Thereof
App 20120329776 - Ren; Pingda ;   et al.
2012-12-27
Certain Chemical Entities, Compositions And Methods
App 20120245169 - Ren; Pingda ;   et al.
2012-09-27
Certain Chemical Entities, Compositions And Methods
App 20120149701 - REN; Pingda ;   et al.
2012-06-14
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
Grant 8,193,182 - Ren , et al. June 5, 2
2012-06-05
Heterocyclic Compounds And Uses Thereof
App 20120122838 - Ren; Pingda ;   et al.
2012-05-17
Chemical Compounds, Compositions And Methods For Kinase Modulation
App 20120059000 - Ren; Pingda ;   et al.
2012-03-08
Heterocyclic Kinase Inhibitors
App 20110281866 - Ren; Pingda ;   et al.
2011-11-17
MTOR Modulators and Uses Thereof
App 20110224223 - Shokat; Kevan M. ;   et al.
2011-09-15
Kinase Inhibitors And Methods Of Use
App 20110172228 - Ren; Pingda ;   et al.
2011-07-14
Benzothiazole Kinase Inhibitors And Methods Of Use
App 20110124641 - Ren; Pingda ;   et al.
2011-05-26
Kinase Inhibitors And Methods Of Use
App 20110077268 - Liu; Yi ;   et al.
2011-03-31
Certain Chemical Entitles, Compositions And Methods
App 20110046165 - Ren; Pingda ;   et al.
2011-02-24
Pyrro[1,2-b]pyridazinone intermediates
Grant 7,842,838 - Webber , et al. November 30, 2
2010-11-30
4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
Grant 7,834,009 - Ellis , et al. November 16, 2
2010-11-16
Benzoxazole kinase inhibitors and methods of use
App 20100190749 - Ren; Pingda ;   et al.
2010-07-29
Benzoxazole kinase inhibitors and methods of use
App 20100184760 - Ren; Pingda ;   et al.
2010-07-22
PYRRO[1,2-b]PYRIDAZINONE COMPOUNDS
App 20090312570 - Webber; Stephen E. ;   et al.
2009-12-17
Certain Chemical Entities, Compositions And Methods
App 20090312319 - Ren; Pingda ;   et al.
2009-12-17
Pyrro[1,2-b]pyridazinone compounds
Grant 7,582,754 - Webber , et al. September 1, 2
2009-09-01
PYRRO[1,2-b]PYRIDAZINONE COMPOUNDS
App 20090105473 - Webber; Stephen E. ;   et al.
2009-04-23
4-Hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
App 20090062263 - Ellis; David ;   et al.
2009-03-05
Pyrro[1,2-b]pyridazinone compounds
Grant 7,462,611 - Ruebsam , et al. December 9, 2
2008-12-09
1-methyl-benzo[1,2,4]thiadiazine 1-oxide Derivatives
App 20080292588 - Zhou; Yuefen ;   et al.
2008-11-27
Pyridazinone compounds
App 20080275032 - Zhou; Yuefen ;   et al.
2008-11-06
Pyridazinone compounds
Grant 7,425,552 - Zhou , et al. September 16, 2
2008-09-16
Lincomycin derivatives possessing antibacterial activity
Grant 7,361,743 - Lewis , et al. April 22, 2
2008-04-22
PYRRO[1,2-b]PYRIDAZINONE COMPOUNDS
App 20080031852 - Webber; Stephen E. ;   et al.
2008-02-07
Pyridazinone compounds
App 20060189602 - Zhou; Yuefen ;   et al.
2006-08-24
Novel lincomycin derivatives possessing antibacterial activity
App 20060148722 - Lewis; Jason G. ;   et al.
2006-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed